JPS57200315A - Antitumor substance - Google Patents

Antitumor substance

Info

Publication number
JPS57200315A
JPS57200315A JP56084956A JP8495681A JPS57200315A JP S57200315 A JPS57200315 A JP S57200315A JP 56084956 A JP56084956 A JP 56084956A JP 8495681 A JP8495681 A JP 8495681A JP S57200315 A JPS57200315 A JP S57200315A
Authority
JP
Japan
Prior art keywords
proteins
cells
substance
water
disintegrating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP56084956A
Other languages
Japanese (ja)
Inventor
Masuko Suzuki
Shigeo Suzuki
Yoshio Okawa
Kazuhiko Hashimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd filed Critical Grelan Pharmaceutical Co Ltd
Priority to JP56084956A priority Critical patent/JPS57200315A/en
Publication of JPS57200315A publication Critical patent/JPS57200315A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PURPOSE: To prepare the titled substance composed of cell walls exhibiting excellent antitumor activity, by disintegrating the cells of Streptoverticillium cinnamoneum dispersed in water or saline water, and removing the lipids and proteins from the supernatant liquid obtained by centrifugal separation.
CONSTITUTION: The objective antitumor substance is composed of cell walls obtained by dispersing the cells of Streptoverticillium cinnamoneum in water or saline water, disintegrating the cells, centrifuging the dispersion at about 1,000G, and removing the lipids and proteins from the resultant supernatant liquid. The substance is peptido-glycan and composed of abount 40% amino acids (as total amino acid), about 14% hexosamine, about 5% total saccharides, about 2% proteins, and about 2% phosphorus. Since the bacterium is a kind of non-pathogenic actinomycetes, it can be handled easily and cultured rapidly, and is suitable for the industrial purpose.
COPYRIGHT: (C)1982,JPO&Japio
JP56084956A 1981-06-04 1981-06-04 Antitumor substance Pending JPS57200315A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP56084956A JPS57200315A (en) 1981-06-04 1981-06-04 Antitumor substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56084956A JPS57200315A (en) 1981-06-04 1981-06-04 Antitumor substance

Publications (1)

Publication Number Publication Date
JPS57200315A true JPS57200315A (en) 1982-12-08

Family

ID=13845078

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56084956A Pending JPS57200315A (en) 1981-06-04 1981-06-04 Antitumor substance

Country Status (1)

Country Link
JP (1) JPS57200315A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01500752A (en) * 1986-06-09 1989-03-16 セル・テクノロジー・インコーポレーテッド biological reaction modifier

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01500752A (en) * 1986-06-09 1989-03-16 セル・テクノロジー・インコーポレーテッド biological reaction modifier

Similar Documents

Publication Publication Date Title
Johnson et al. The composition and fluidity of normal and leukaemic or lymphomatous lymphocyte plasma membranes in mouse and man
JPS557014A (en) Antitumor agent and its preparation
JPS5765178A (en) Plant tissue or cell culture
EP0393035A1 (en) Method for the isolation of active enzyme(s) from krill tissue.
ICHIMASA et al. Purification and properties of a membrane-bound phospholipase B from baker's yeast (Saccharomyces cerevisiae)
JPS57144983A (en) Preparation of physiologically active substance
Kucerova et al. Separation of human pepsin and gastricsin by affinity chromatography with an immobilized synthetic inhibitor
Yoo et al. Environmental Studies Of The Jinhae Bay 2. Environmental Parameters In Relation To Phytoplankton Population Dynamics.
Miyakawa et al. In vivo and in vitro stimulatory effect of mating pheromone on the endogenous protein phosphorylation in Rhodosporidium toruloides
JPS557205A (en) New antiulcerative substance, its preparation and antiylcer containing thereof as effective component
JPS5548393A (en) Preparation of c-type cytochrome
Nachmias Adenosine 5′-phosphate and assembly of actin filaments in vitro
Majumdar Effect of tryptophan on hepatic nuclear free and engaged RNA-polymerases in young and adult rats
JPS568686A (en) Preparation of galactose oxidase
JPS56125310A (en) Preparation of protein solution consisting essentially of lipoprotein of plasma with high specific gravity and serum albumin
JPS5513204A (en) Active compound having delayed allergic activity and anticarcinogenic activity, and its preparation
SPRAGUE The electrophoretic patterns of skipjack tuna tissue esterases
JPS55135588A (en) Preparation of heat-resistant catalase
JPS5362786A (en) Washing method for membrane in electric dialysis
Borrebaek et al. Enzymic removal of glucose 6-phosphate from fructose 6-phosphate preparations
Gao et al. Electrodialysis of Sc exp 3+ through chitose linking membrane
JPS561867A (en) Preparation of yeast extract
Kostenko et al. Subcellular and submitochondrial localization of inorganic pyrophosphatase in the mammalian heart and liver
Narasaki et al. Purification of the Lipoprotein Lipases Produced by Pseudomonas sp. M-12-33
Lloyd et al. Observations on rat mast-cell-granule protease